What is Hangzhou Tigermed Consulting Co Operating Cash Flow per Share?
Hangzhou Tigermed Consulting Co's operating cash flow per share for the
three
months ended in Mar. 2024 was ¥0.17.
Hangzhou Tigermed Consulting Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.46.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hangzhou Tigermed Consulting Co was 16.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 35.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Operating Cash Flow per Share or its related term are showing as below:
SZSE:300347'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -19.7 Med: 32.2 Max: 116.7
Current: 2.1
During the past 13 years, Hangzhou Tigermed Consulting Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 116.70% per year. The lowest was -19.70% per year. And the median was 32.20% per year.
SZSE:300347's 3-Year OCF Growth Rate is ranked better than 50.28% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 2
vs SZSE:300347: 2.10
Hangzhou Tigermed Consulting Co Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hangzhou Tigermed Consulting Co Operating Cash Flow per Share Chart
Competitive Comparison of Hangzhou Tigermed Consulting Co's Operating Cash Flow per Share
For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow falls into.
Hangzhou Tigermed Consulting Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Hangzhou Tigermed Consulting Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300347 has been successfully added to your 